Chemical and Pharmaceutical Bulletin p. 1510 - 1520 (1996)
Update date:2022-08-02
Topics:
Sakurai, Shunichiro
Ogawa, Nobuo
Suzuki, Tomio
Kato, Ken-Ichi
Ohashi, Tetsuo
Yasuda, Shingo
Kato, Hideo
As part of our search for a dual inhibitor possessing both thromboxane A2 (TXA2) receptor antagonistic and TXA2 synthase inhibitory activities, some [[(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives possessing a pyridyl or imidazolyl group were synthesized. Their TXA2 receptor antagonistic and TXA2 synthase inhibitory activities were evaluated in terms of the inhibitory effects on U-46619-induced guinea-pig platelet aggregation and on thromboxane B2 (TXB2) production in human platelets, respectively. It was found that 3-[4-[2-(1-imidazolyl)1-(4- chlorobenzenesulfonamido)ethyl]phenyl]propionic acid (22a), containing an imidazolyl group, is a well-balanced dual inhibitor having both TXA2 receptor antagonistic activity (IC50=0.31 μM) and TXA2 synthase inhibitory activity (IC50=0.39 μM).
View MoreTianjin SPHINX SCIENTIFIC LAB.
Contact:+86-022-66211289
Address:Tianda high-tech Park. No.80,the 4th Avenue
Jiangsu Dacheng Pharmaceutical and Chemical Co.,Ltd
Contact:+86-0517-87036900
Address:Chuzhou Chemical park, Huai'an, Jiangsu Province
Taizhou Shengxing Chempharm Co.,Ltd
Contact:+86-576-88516600
Address:Yantou Chemical Zone Jiaojiang Taizhou Zhejiang China
Zhuhai Rundu Pharmaceutical co.,Ltd
Contact:+86-756-7630755
Address:No.6,North Airport Road,Sanzao Town,Jinwan District
YingYing Pharmaceutical Co.,Ltd
Contact:86-18854126208
Address:55#, yingxiongshan road
Doi:10.1016/j.tetlet.2007.08.108
(2007)Doi:10.1016/0040-4039(96)01504-3
(1996)Doi:10.1016/j.tetlet.2014.10.043
(2014)Doi:10.1016/S0040-4039(00)74478-9
(1991)Doi:10.1016/0040-4020(96)00652-7
(1996)Doi:10.1016/0040-4020(96)00613-8
(1996)
